Clinical Bioequivalence Study on Two Methyldopa Tablet 250mg Formulations
Clinical trial NCT03210025 · COMPLETED
Trial details
- NCT number
- NCT03210025
- Sponsor
- Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-20
- Primary completion
- 2017-10-15
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.